HomeCTXR • NASDAQ
add
Citius Pharmaceuticals Inc
Previous close
$0.73
Day range
$0.64 - $0.69
Year range
$0.60 - $1.56
Market cap
104.16M USD
Avg Volume
1.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.34M | 28.84% |
Net income | -9.23M | -156.88% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.34M | -28.85% |
Effective tax rate | -1.58% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 20.35M | -44.84% |
Total assets | 97.40M | -12.81% |
Total liabilities | 12.07M | 13.06% |
Total equity | 85.33M | — |
Shares outstanding | 159.09M | — |
Price to book | 1.38 | — |
Return on assets | -23.23% | — |
Return on capital | -26.29% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.23M | -156.88% |
Cash from operations | -6.14M | -27.17% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -6.14M | -27.17% |
Free cash flow | -2.83M | 51.63% |
About
Founded
2007
Headquarters
Website
Employees
22